US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

This blue chip is releasing its eagerly anticipated results next week. Here's what to expect. The post Own CSL shares? Here's ...

Jan. 30, 2025 — Zika virus hijacks the skin of its human host to send out chemical signals that lure more mosquitoes to infect and spread the disease further, new research ...

The biotechnology company’s hybrid caviar targets B2B partnerships in luxury dining, reflecting a broader shift among ...

After hours: January 31 at 7:54:08 p.m. EST Loading Chart for BLUE ...

After hours: January 31 at 4:49:05 PM EST Loading Chart for PBYI ...

Beyond its scientific value, the project is also a key element in strengthening India’s blue economy, contributing to both ...

Madhuri Kukreja spent two and a half years working at a financial services company as an entry level analyst. It was ...

These shares are highly rated by analysts at Bell Potter. But why? The post 2 high-quality ASX 200 blue chip shares to buy ...